CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Lumosa Therapeutics Co., Ltd.

For profitWebsite ↗

Also known as: Lumosa Phase 1 unit | Lumosa Therapeutics | Lumosa Therapeutics Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 1, 2022

Timeline

2000s

Jun 1, 2001
Lumosa Therapeutics Co., Ltd.— Founded

Drugs by trial phase (8 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

sebacoyl dinalbuphine ester

Phase 2 (2 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (10)

NCT05403866Lead sponsorPhase 2Jun 1, 2022
NCT05198323Lead sponsorPhase 2Feb 1, 2022
NCT04809818Study directorPhase 1Mar 21, 2021
NCT04809818Lead sponsorPhase 1Mar 21, 2021
NCT04393675Lead sponsorPhase 1/Phase 2May 15, 2020
NCT04393675Study directorPhase 1/Phase 2May 15, 2020
NCT04256434Lead sponsorPhase 1Jan 28, 2020
NCT04091945Lead sponsorPhase 2Sep 30, 2019
NCT02446301Lead sponsorPhase 1Jan 1, 2015
NCT02468128Lead sponsorPhase 2/Phase 3Dec 1, 2012

Details

Founded: Taipei, TW Jun 1, 2001
Last known activity: Jun 1, 2022